INTRODUCTION
============

The innate immune response in vertebrates, mediated by neutrophils, macrophages and dendritic cells, is the first line of defense against invading microorganisms. These cells can discriminate between pathogens and self by utilizing signals from Toll-like receptors (TLRs). TLRs enable the innate immune system to recognize specific pathogen associated molecular patterns (PAMPs) as well as induce specific cytokine profiles bringing a certain degree of specificity to the innate immune system, thereby influencing the nature of the adaptive immune response. The mammalian TLR multi-gene family comprises of at least 11 members, of which TLRs 1-9 are conserved between humans and mouse. These are Type1 transmembrane proteins and have been grouped into the same gene family due to their sequence similarity ([@b7-ajas-25-7-1021-17]). The complete set of TLRs can detect a broad variety of microorganisms, viz; bacteria, viruses, fungi and even some protozoa. Among the known TLRs, TLR2 is primarily implicated in recognition of Gram-positive bacterial cell wall components, especially peptidoglycan (PGN). Grampositive bacterial PGN activates cells primarily through TLR2 which results in the activation of the transcription factor NF-κB, a ubiquitous factor, that regulates the transcription of various cytokine genes involved in immune responses ([@b23-ajas-25-7-1021-17]). These cytokines provide a polarizing signal, which constitutes one of the three distinct signals required for the activation of T cells by antigen presenting cells. Among the cytokines, IL-12 production tailors a Th1-type response, whereas IL-4 and IL-10 activate mainly Th2-type responses ([@b10-ajas-25-7-1021-17]). Depending upon the type of infectious agent, TLRs cause skewing towards the production of either pro-inflammatory Th1 type cytokines (IL-12, IFN-γ and TNF-α) or Th2 type cytokines, viz; IL-4 and IL-10, which are associated with the promotion of IgE and are anti-inflammatory in response ([@b22-ajas-25-7-1021-17]). Recent research on vaccine development has focused on adjuvant improvement which can promote stable induction of Th1 immunity with minimal side effects by investigating ways to redirect Th2 responses in favour of Th1 responses. TLRs have been suggested to function as the desirable vaccine adjuvants ([@b8-ajas-25-7-1021-17]). TLR2 is the most promiscuous of all the TLRs and has received an extra attention due to contrasting opinions about its ligand specificity and thereby differential cytokine induction ([@b21-ajas-25-7-1021-17]; [@b5-ajas-25-7-1021-17]). Furthermore, the health and infectious diseases of buffalo are currently being managed much like those of cattle which however, especially of young calves, are different. To successfully adapt cattle-based strategies of health management to buffalo, it is necessary to understand their immune system as well as the variables involved in differential disease susceptibility and resistance. Such studies will not only contribute to improvement in the management of buffalo, but will also provide an insight into the mechanisms accounting for the differences in disease resistance ([@b19-ajas-25-7-1021-17]). In this context, the present study was conducted to study the cytokine response by buffalo peripheral blood mononuclear cells, under culture conditions, to *B. subtilis* cell wall peptidoglycan in a dose- and time- dependent manner.

MATERIALS AND METHODS
=====================

PBMC isolation, recovery and viability
--------------------------------------

Blood samples were collected from six healthy and immunocompetent Murrah buffalo heifers, aged two and a half years, maintained at Dairy farm, GADVASU, Ludhiana. Fifteen ml of blood per heifer was collected in 0.5 M EDTA aseptically and stored at 4°C till further use. The blood samples were processed within two hours for peripheral blood mononuclear cell (PBMCs) isolation by density gradient centrifugation, using Histopaque 1077 (Sigma, USA). Briefly, five ml of the collected blood sample was diluted in equal volume of phosphate buffered saline (PBS, pH 7.4) and layered over onto the equal volume of Histopaque 1077 (Sigma, USA), followed by centrifugation at 400 g for 25 min, break off, at room temperature. The buffy layer, containing mononuclear cells, was separated, washed twice with RPMI-1640 media, supplemented with 10mM HEPES, 50 μg/ml Gentamicin, 100 IU/ml of Penicillin, 100 μg/ml Streptomycin and 0.25 μg/ml Amphotericin, and sedimented to a pellet at 200 g for 10 min. The recovery and viability of the isolated PBMCs was determined by haemocytometer counting, using trypan blue dye exclusion method. 10 μl of the cell suspension was mixed with 10 μl of 0.4% trypan blue and incubated for 3 to 5 min at room temperature. 10 μl of this mixture was injected beneath the cover slip on a haemacytometer. The unstained (viable) and stained (dead) cells were counted from the central large squares of haemacytometer. The total number of viable cells counted on an average was 2.4× 10^6^/ml, accounting for 91% viability.

PBMC culture and stimulation
----------------------------

500 μl of the isolated PBMC suspension per ml of the culture volume (2.4×10^6^ viable cells/ml), was cultured in RPMI-1640 medium supplemented with HEPES Buffer (10 mM), L-glutamine (2 mM), Gentamicin (50 μg/ml), Pencillin (100 IU/ml), Streptomycin (100 μg/ml) and Amphotericin B (0.25 μg/ml) and stimulated with peptidoglycan (sPGN) of *Bacillus subtilis* cell wall origin (Sigma Life sciences, USA) in a dose- and time- dependent manner. The working concentration of the soluble petidoglycan (sPGN), prepared in sterile tissue culture grade endotoxin free water, was 1 μg/μl. The cultures in 6-well tissue culture plates were stimulated with 10, 20, 30, 40 and 50 μg/ml final dose of sPGN. A non-stimulated culture plate acted as the control. The cultures were incubated at 37°C and 5% CO~2~ under humidified conditions for 3 h, 12 h, 24 h and 36 h time periods with media changes every 12 h. All the culture wells were microscopically examined at appropriate intervals to rule out bacterial and fungal contamination.

Extraction of total RNA
-----------------------

After the respective incubation periods, the total RNA from the cultured PBMCs was extracted using Tri reagent (MRC, Inc.) as per the manufacturer's protocol with slight modifications. Briefly, 1ml Tri reagent was added to the pellet, lysed by repetitive pipetting, followed by addition of 1ml chloroform. After vortexing the tubes were kept at room temperature for 15 min, then centrifuged at 10,000 rpm for 10 min at 4°C. 600 μl of the aqueous phase, containing total RNA, was aspirated out and equal volume of isopropanol added, followed by incubation at room temperature for 1 h RNA pellet was obtained by centrifugation at 10,000 rpm for 10 min at 4°C, washed with 70% ethanol, air-dried and finally dissolved in 0.1% DEPC treated water and incubated at 56°C for 15 min The extracted RNA was quantified and checked for purity in Nano drop. Its integrity was further checked by Experion automated electrophoresis system which showed distinct peaks for 18S and 28S ribosomal RNA (rRNA) indicating that the RNA was pure and without any shearing or fragmentation.

Reverse transcription-PCR
-------------------------

The samples with 260/280 greater than 1.9 were used for cDNA synthesis employing QuantiTect reverse Transcription Kit (Qiagen). First the genomic DNA elimination reaction was prepared on ice by adding 2 μl of gDNA Wipeout Buffer (7×) to 1 μl of template RNA (1,000 ng) in 11 μl of RNase-free water. The reaction mixture was incubated for 2 min at 42°C, then immediately placed on ice. This template RNA reaction (14 μl) was added to the preformed reverse transcription master mix which was prepared on ice by addition of 1 μl of Quantiscript Reverse Transcriptase, 4 μl of Quantiscript RT Buffer (5×) and 1 μl of RT Primer Mix. The tubes were incubated for 25 min at 42°C in water bath, followed by inactivation at 95°C for 3 min. The amplification of 218 bp GAPDH gene fragment from the cDNA indicated the presence of cDNA.

Real-time PCR
-------------

Quantitative real-time PCR was performed using 7500 RT-PCR instrument (ABS) to study the relative gene expression of TLR2, IL-12, IFN-γ, TNF-α, IL-4 and IL-10, using gene specific primer- probe combinations (Sigma Aldrich, USA), by Taqman chemistry. The software package, Primer Express version 3.0, was used to identify appropriate TaqMan primer- probe sets for the respective genes selected ([Table 1](#t1-ajas-25-7-1021-17){ref-type="table"}). The primer-probe set for TLR2 was obtained from its EST, sequenced earlier in the lab ([@b17-ajas-25-7-1021-17]); (Genbank accession No. GU441859.1). The optimized qRT-PCR reaction contained 100 ng of cDNA, 900 nM of each of the primer and 200 nM of the probe in a final volume of 20 μl. The reactions were run in triplicate using GAPDH as an endogenous control. The thermal cycling parameters, 50°C for 2 min for AmpErase UNG activation, 95°C for 10 min for AmpliTaq Gold DNA Pol. activation and 40 cycles of each 95°C for 15 s for denaturation/melting and 60°C for 1 min for annealing and extension, yielded optimum amplification. For the test genes and endogenous control standards 10-fold serial dilutions were run in the study to estimate the efficiency of PCR and the percentage efficiency ranged between 90 to 100%. The relative expression of each sample was calculated using the 2^−△△CT^ method ([@b16-ajas-25-7-1021-17]). Results were analyzed and shown as fold change (log~10~ relative quantification) relative to the control group.

Statistical analysis
--------------------

Analysis of variance with Dunett's test was used to compare the different groups with the control (JMP 8.0). The data are mean triplicate of the three experiments. Differences were considered significant at p≤0.05.

RESULTS
=======

After 3 h incubation, the relative expression of TLR2 gene was found to increase in dose- dependent manner. Its expression was highest at 30 μg/ml dose of sPGN. The relative expression of IL-4 followed a general increasing trend as the dose of sPGN increased, being highest at 30 μg/ml. It was greater than all other cytokines at all doses of sPGN. The relative expression of IL-10 was highest at 20 μg/ml sPGN dose, after which it decreased. IL-12 expression was greater than that of non- stimulated control, remained stable upto 30 μg/ml sPGN concentration beyond which it decreased more pronouncedly than IL-4. The relative expression of IFN-γ was highest at 20 μg/ml sPGN dose after which it was lesser than that of the non-stimulated control. TNF-α showed increased relative expression at all doses of the antigen with respect to the control, being highest at 20 μg/ml dose and least at 50 μg/ml dose of the antigen. At 50 μg/ml dose of sPGN, i.e. at higher concentrations, the relative expression of IL-4 was greater than other cytokines thereby tailoring a Th2 type cytokine response ([Figure 1](#f1-ajas-25-7-1021-17){ref-type="fig"}). The correlation between the sPGN dose and TLR2 expression was positive (0.563; p\<0.05). The correlations were also positive between: induction of TLR2 and IL-4 (0.923; p\<0.05), TLR2 and IL-10 (0.752; p\<0.05) and TLR2 and IL-12 (0.646; p\<0.05). At 12 h incubation, the relative expression of TLR2 gene increased with respect to non- stimulated control in all the treatment groups. The kinetics of increase was concentration dependent being highest at 30 μg/ml dose of sPGN. The relative expression of IL-4 and IL-10 was down regulated after 20 μg/ml sPGN dose. IL-12 showed dose-dependent increase in its expression, highest at 50 μg/ml. The expression of IFN-γ and TNF-α was highest at 20 μg/ml dose, after which the later showed a more drastic decrease than the former. A general trend followed in which the expression of Th2 type cytokines decreased more pronouncedly than Th1 type cytokines ([Figure 2](#f2-ajas-25-7-1021-17){ref-type="fig"}). Thus, at higher concentrations of antigen and for longer incubation periods, sPGN favoured a Th1 type bias. The correlation was positive between sPGN dose and TLR2 expression (0.76; p\<0.05) and between TLR2 and IL-12 expression (0.537; p\<0.05), while TLR2 and IL-4 expressions were negatively correlated (−0.068; p\<0.05). The relative gene expression study of TLR2 for 24 h incubation period showed an increasing trend till 40 μg/ml dose of sPGN. IL-4 and IL-10 showed greater expression than that of the control at 10 μg/ml dose of sPGN only. The relative expression of IL-12 was positive throughout, increasing in a dose-dependent manner till 40 μg/ml. The relative expression of IFN-γ and TNF-α also showed the dose-dependent increase ([Figure 3](#f3-ajas-25-7-1021-17){ref-type="fig"}). The relative expression of IL-12 with respect to the control was greater than that of all other cytokines at all sPGN doses across all incubation intervals, thereby tailoring the response towards Th1 type. Its expression pattern was almost similar to that of TLR2 showing that TLR2 signaling cascades have a direct impact on governing the cytokine profile in response to an antigen. The correlations, between sPGN dose and TLR2 (0.873; p\<0.05) and TLR2 and IL-12 (0.801; p\<0.05) were positive, while TLR2 and IL-4 were negatively correlated (−0.0687; p\<0.05). The quantification of mRNA for 36 h incubation periods revealed that the expression of TLR2 increased proportionately till 20 μg/ml dose of sPGN and decreased thereon. The expression of IL-4 and IL-10 was greater than control at 10 and 20 μg/ml dose of sPGN while IL-12 showed decreased expression across all antigen doses. The relative expression of IFN-γ and TNF-α was highest at 10 μg/ml dose of the antigen beyond which it was lower than that of the control ([Figure 4](#f4-ajas-25-7-1021-17){ref-type="fig"}). The correlation was positive between sPGN dose and TLR2 expression (0.0676; p\<0.05) and between TLR2 and IL-4 (0.0146; p\<0.05); and negative between TLR2 and IL-12 (−0.0454; p\<0.05). The overall cytokine induction profile, taken as the net average, for an incubation period is depicted in [Table 2](#t2-ajas-25-7-1021-17){ref-type="table"}.

DISCUSSION
==========

The relative increase in TLR2 expression at all doses for all incubation periods is due to induction caused by sPGN stimulation which is the ligand for TLR2 that activates its transcription ([@b2-ajas-25-7-1021-17]). Its expression is further up regulated *in vitro* by autocrine cytokines, IL-10 and TNF-α which are produced by the stimulated PBMCs ([@b24-ajas-25-7-1021-17]). The decrease in expression of TLR2 beyond 30 μg/ml dose of sPGN may be due to sPGN induced tolerance ([@b12-ajas-25-7-1021-17]) and concomitant decrease in its up regulating cytokines, as observed in our study.

At 3 h incubation period the initial increased production of both Th1 and Th2 type cytokines at lower sPGN doses may be due to a very high proportion of CD4^−^ CD8^−^ T cells in peripheral blood lymphocytes in bovines (15 to 30%) which represent a Th0 subpopulation that secrete a mixture of cytokines, especially IL-12 and IL-4, representatives of both Th1 and Th2 subtypes ([@b20-ajas-25-7-1021-17]). It has been reported earlier that if both IL-12 and IL-4 are present at the time of T cell activation, the effect of the IL-4 dominates and the T lymphocytes polarize to become Th2 effectors ([@b14-ajas-25-7-1021-17]). Further the ligation of the IL-4 receptor on Th0 cells triggers activation of signal transducer and activator of transcription 6 (STAT6) which suppresses Th1 polarization and leads to Th2 polarization ([@b18-ajas-25-7-1021-17]). Thus the Th2 polarization, as observed in our study, is primarily due to more relative expression of IL-4 than IL-10 which directly enhances the development of Th2 cells from naïve T cells ([@b1-ajas-25-7-1021-17]). IL-10 further inhibits the production of IL-12, IFN-γ and TNF-α thereby explaining the decrease in their relative expressions ([@b4-ajas-25-7-1021-17]). The findings reveal that the activation of TLR2 by sPGN at smaller incubation intervals induces skewing towards Th2 development as observed by [@b8-ajas-25-7-1021-17] in their studies. Thus, *in vitro*, stimulation of PBMCs with higher doses of sPGN for shorter periods of time (3 h) causes differentiation of naive T cells preferentially into Th2 sub group. At the longer incubation time of 12 h, with increasing sPGN dose, the decrease in the expression of IL-4 was more pronounced than IL-12 overcoming its dominating effect as observed at shorter incubation (3 h). The expression of IL-12 was more profound than IL-4, inferring that at higher concentrations of antigen and for greater periods of exposure, naïve T cells showed Th1 polarization. IL-12 acts synergistically with IFN-γ and down regulates Th2 type cellular proliferation and activation, thereby explaining the reason for lower relative expression of Th2 type cytokines ([@b11-ajas-25-7-1021-17]). Thus, it might be concluded that moderate doses of antigen favoured Th2 type bias whereas higher doses of antigen favoured Th1 type cytokine pattern, almost in accordance to the observations made by [@b13-ajas-25-7-1021-17] who concluded that both low and high amounts of antigen, *in vitro*, primed for Th1 type whereas moderate levels stimulated Th2 type cytokine release ([@b13-ajas-25-7-1021-17]). At 24 h incubation period, the peptidoglycan induced tolerance at 30 μg/ml dose was not observed. This may be due to relatively more expression of TNF-α at 40 μg/ml dose, an up regulator of TLR2 ([@b24-ajas-25-7-1021-17]), at this incubation. The expression pattern of IL-12 was almost similar to that of TLR2 showing that TLR2 signaling cascades have a direct impact on governing cytokine profile in response to an antigen in a dose- and time- dependent manner. The highest expression of IL-4 and IL-10 at 10 μg/ml dose of sPGN may be due to a lower requirement of antigen dose for naïve T cells to secrete IL-4 ([@b6-ajas-25-7-1021-17]). But for greater incubation periods and at higher antigen doses the naïve T cells shifted towards IL-12 producing subset, thereby governing the Th1 type response ([@b15-ajas-25-7-1021-17]). An overall similar cytokine induction pattern, obtained at 12 and 24 h incubations might be suggestive of the optimum physiological response to the antigen. The cells became refractory to the peptidoglycan stimulation at longer incubation times, indicated by the decreased expression profile of all the cytokines at 36 h incubation, under the study. The overall decrease in expression of all the cytokines might also be due to cellular apoptosis induced by TLR2 ([@b3-ajas-25-7-1021-17]). The initial polarization towards Th2 type from the earlier Th1 type response indicated the effect of the dose and duration of exposure to an antigen on Th1/Th2 bias. This switching of immune response from Th2 type (3 h) to Th1 type (12 and 24 h) and again to Th2 type (36 h) may be due to wide range of antigen concentrations used in the studies (0 to 50 μg/ml) and the wide duration (3 to 36 h) of exposure of the cultures to the antigen. This observation is in accordance with the two antigenic switches, Th1 to Th2 to Th1, as reported by [@b9-ajas-25-7-1021-17].

CONCLUSION
==========

The study gives an indication that the induction of a distinct Th phenotype is not dependent on a particular DC lineage but instead, depends on the state of activation and maturation of the DC and the TLR2 agonists could be used as effective vaccine adjuvants to direct the immune response towards Th1 type which is a key consideration in development of modern vaccines.
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###### 

Primers and probes for qRT-PCR

  Gene                                                       Sequence (5' to 3')       Len.   Tm (°C)
  ------------------- -------------------------------------- ------------------------- ------ ---------
  TLR2 (GU44I859.1)   Forward                                CTGGCCCTTCCTTCAAACC       19     65.7
  Reverse             TCCCGTTTTTTCTAGTGATTTCAAA              25                        65.2   
  Probe               \[6FAM\]TGGTTTTAAGGCAGAATC\[BHQ1\]     18                        55.0   
  IL-4 (AY293620)     Forward                                GCCACACGTGCTTGAACAAA      20     67.2
  Reverse             TGCCAAGCTGTTGAGATTCCT                  21                        66.0   
  Probe               \[6FAM\]CCTGGGCGGACTC\[BHQ1\]          13                        53.0   
  IL-10 (AB246351)    Forward                                TGCCACAGGCTGAGAACCA       19     68.3
  Reverse             TCTCCCCCAGCGAGTTCA                     18                        67.2   
  Probe               \[6FAM\]CCTGACATCAAGGAGCA\[BHQ1\]      17                        58.0   
  IL-12 (EF424254)    Forward                                AAAAGCAGCAGAGGCTCCT       19     58.0
  Reverse             GTCCACGCTGACCTTCTCT                    19                        56.0   
  Probe               \[6FAM\]CTGCTCCGCACGTCAG\[BHQ1\]       16                        55.0   
  IFN-γ (EF424252)    Forward                                TGAATGACCTGTCGCCAAAAT     21     66.4
  Reverse             GGCCTCGAAAGAGATTCTGACTT                23                        65.7   
  Probe               \[6FAM\]ACCTCAGAAAGCGGAAG\[BHQ1\]      17                        58.0   
  TNF-α (EF424254)    Forward                                ACTCATATGCCAATGCCCTCATG   23     59.0
  Reverse             GCAGGCACCACCAGCT                       16                        57.0   
  Probe               \[6FAM\]ACGGCGTGAAGCTAG\[BHQ1\]        15                        57.0   
  GAPDH (DQ882684)    Forward                                GAAGGTGAAGGTCGGAGTC       19     57.0
  Reverse             GAAGATGGTGATGGGATTTC                   20                        58.0   
  Probe               \[6FAM\]CAAGCTTCCCGTTCTCAGCC\[BHQ1\]   20                        55.0   

###### 

Average cytokine inductions at different incubation intervals

  Incubation time (h)   Cytokine levels
  --------------------- ------------------------------------
  3                     IL-4\>IL-10\>TNF-α\>IL-12\>IFN-γ
  12                    IL-12\>IFN-γ\>TNF-α\>IL-10\>IL-4
  24                    IL-12\>IFN-γ\>TNF-α\>IL-10 \> IL-4
  36                    TNF-α\>IL-10\>IL-4\> IFN-γ\>L-12
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